Living donor transplant education for African American patients with end-stage renal disease

被引:44
作者
Arriola, Kimberly R. Jacob [1 ]
Powell, C. Lamonte [1 ]
Thompson, Nancy J. [1 ]
Perryman, Jennie P. [2 ]
Basu, Mohua [1 ]
机构
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Transplant Ctr, Atlanta, GA USA
关键词
RANDOMIZED CONTROLLED-TRIAL; KIDNEY-TRANSPLANTATION; ORGAN DONATION; RACIAL DISPARITIES; INTERVENTION; BARRIERS; TALK; WILLINGNESS; PREFERENCES; CANDIDATES;
D O I
10.7182/pit2014830
中图分类号
R61 [外科手术学];
学科分类号
摘要
Context-Despite numerous benefits of live donor kidney transplant (LDKT), patient-level barriers often prevent African Americans from considering LDKT. Educational interventions designed to address patient-level barriers may increase willingness among African American patients with end-stage renal disease to explore LDKT as a treatment option. Objective-To assess the effectiveness of a culturally sensitive educational inter-vention called Living ACTS (About Choices in Transplantation and Sharing) that was designed to address patient-level barriers to LDKT among African American patients with end-stage renal disease. Design/Participants-Patients were randomized to intervention (n = 136) or control (n =132) groups. They completed baseline measures and then viewed either the Living ACTS or control video. Both groups then completed an immediate followup measure and a 6-month assessment administered via telephone. Main Outcome Measures-Self-reported knowledge about LDKT, willingness to talk to the patient's family about LDKT, and perceived benefits of LDKT were measured at 3 time points. Results-At 6-month follow-up, intervention participants demonstrated a significantly greater increase in knowledge of LDKT than control participants (F-2,F-229=3.08, P=.05). Intervention participants expressed greater willingness to talk to patients' families about LDKT than did control participants from baseline through 6-month follow-up (F-1,F-230 = 7.11, P=.008). Finally, at immediate follow-up, intervention participants reported greater endorsement of the benefits of LDKT than did control participants (F-2,F-23=14.27, P < .001); however, this effect had disappeared by the 6-month follow-up. Conclusions Living ACTS is effective at increasing and maintaining knowledge about LDKT among African American patients with end-stage renal disease who are considering transplant. (C) 2014 NATCO, The Organization for Transplant Professionals
引用
收藏
页码:362 / 370
页数:9
相关论文
共 50 条
  • [31] Nephrologists' Perceptions of Renal Transplant as Treatment of Choice for End-stage Renal Disease, Preemptive Transplant, and Transplanting Older Patients: An International Survey
    Ghahramani, Nasrollah
    Karparvar, Zahra Yeganeh
    Ghahramani, Mehrdad
    Shrivastava, Pritika
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (04) : 223 - 229
  • [32] Causes and timing of end-stage renal disease after living kidney donation
    Matas, Arthur J.
    Berglund, Danielle M.
    Vock, David M.
    Ibrahim, Hassan N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (05) : 1140 - 1150
  • [33] Comparative Effectiveness of Liver Transplant Strategies for End-Stage Liver Disease Patients on Renal Replacement Therapy
    Chang, Yaojen
    Gallon, Lorenzo
    Jay, Colleen
    Shetty, Kirti
    Ho, Bing
    Levitsky, Josh
    Baker, Talia
    Ladner, Daniela
    Friedewald, John
    Abecassis, Michael
    Hazen, Gordon
    Skaro, Anton I.
    LIVER TRANSPLANTATION, 2014, 20 (09) : 1034 - 1044
  • [34] Bariatric Surgery as a Bridge to Renal Transplantation in Patients with End-Stage Renal Disease
    Al-Bahri, Shadi
    Fakhry, Tannous K.
    Gonzalvo, John Paul
    Murr, Michel M.
    OBESITY SURGERY, 2017, 27 (11) : 2951 - 2955
  • [35] Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study
    Jeon, Hong Jae
    Bae, Hong Jin
    Ham, Young Rok
    Choi, Dae Eun
    Na, Ki Ryang
    Ahn, Moon-Sang
    Lee, Kang Wook
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (01) : 116 - 123
  • [36] Postural balance, muscle strength, and history of falls in end-stage renal disease patients living with a kidney transplant: A cross-sectional study
    Zanotto, Tobia
    Gobbo, Stefano
    Bullo, Valentina
    Vendramin, Barbara
    Roma, Enrico
    Duregon, Federica
    Bocalini, Danilo Sales
    Di Blasio, Andrea
    Cugusi, Lucia
    Furian, Lucrezia
    Di Bella, Caterina
    Neunhaeuserer, Daniel
    Battista, Francesca
    Bergamin, Marco
    Ermolao, Andrea
    GAIT & POSTURE, 2020, 76 : 358 - 363
  • [37] Role of homocysteine in end-stage renal disease
    Wu, Chia-Chao
    Zheng, Cai-Mei
    Lin, Yuh-Feng
    Lo, Lan
    Liao, Min-Tser
    Lu, Kuo-Cheng
    CLINICAL BIOCHEMISTRY, 2012, 45 (16-17) : 1286 - 1294
  • [38] Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients
    Hung, Shih-Yuan
    Lin, Tsun-Mei
    Chang, Min-Yu
    Wang, Hsi-Hao
    Lee, Yi-Che
    Ho, Li-Chun
    Chen, Yi-Ting
    Hung, Chi-Ming
    Liou, Hung-Hsiang
    HUMAN IMMUNOLOGY, 2014, 75 (06) : 531 - 535
  • [39] End-stage renal disease measures of quality
    Himmelfarb, Jonathan
    Kliger, Alan S.
    ANNUAL REVIEW OF MEDICINE, 2007, 58 : 387 - 399
  • [40] A third kidney transplant: Cost-effective treatment for end-stage renal disease?
    Matas, AJ
    Gillingham, KJ
    Payne, WD
    Dunn, DL
    Gruessner, RWG
    Sutherland, DER
    Schmidt, W
    Najarian, JS
    CLINICAL TRANSPLANTATION, 1996, 10 (06) : 516 - 520